AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2018
Aug 13, 2018
32414_dirs_2018-08-13_6594f2d5-211f-495c-907b-47b8d1acab48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-08-09
Reporting Person: Gold Mark Stephen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-09 | Common Stock | G | 30487 | — | Disposed | 344761 | Direct |
Footnotes
F1: The shares of common stock for Dr. Gold include 212,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 92,000 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. The transaction reflected on this Form 4 relates to the transfer by MJKS, Ltd. of an aggregate of 30,487 shares of common stock to Dr. Gold's adult children who do not share a household with Dr. Gold.
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3